Kolabtree Joins $175 Million NASA Innovation Project

NASA to access expertise of Kolabtree’s scientific experts

Kolabtree, the world’s largest platform for scientific freelancers, has joined NASA’s Open Innovation Services (NOIS2) program. As one of 13 new partners, Kolabtree will connect its highly qualified network of freelance scientists with NASA’s engineers, scientists and researchers, to help them solve their most complex technical challenges. As part of the project, Kolabtree is acting as a new avenue for NASA to scout subject matter experts (SMEs) from outside the organization.

2022 marks the third iteration of the NOIS project, where its efforts to foster enhanced collaboration include raising the ceiling value of NOIS from $24.9 to $175 million. It will see NASA run challenges that task partner companies with solving some of its most difficult technical problems. Using the additional touchpoints created by this program, NASA can take advantage of independent expertise to help test new ideas, further ground-breaking research, build prototypes and standardize best practises.

Kolabtree is an open talent platform that provides businesses with access to a global network of more than 20,000 scientific researchers, academics and industry consultants, many of them PhD qualified. Its scientific consultants bring knowledge from more than 2,000 scientific disciplines, and work for leading institutions including MIT, Harvard and The University of Cambridge. Kolabtree joining the program means NASA can put forward problem-statements to Kolabtree’s freelancers, who have the opportunity to provide a solution.

“NOIS2 sees a monumental commitment from NASA to accessing talent externally,” said Ashmita Das, CEO and co-founder of Kolabtree. “It ties in closely with Kolabtree’s mission to democratize access to scientific expertise, by facilitating easy collaboration between businesses and academia. Programs like this are testament to the fact that highly specialised industry experts are incredibly difficult to access on a short-term basis, even for an organization as renowned as NASA.”

The contract is run through the National Tournament Lab (NTL), which is building a global network of specialists that can be accessed to develop new technologies, share best practises and measure and evaluate results. Kolabtree and the other new additions join 19  companies that began working with NASA in 2020.

For more information about the NOIS2 visit https://www.nasa.gov/coeci/ntl. If you’re working on a scientific project that may benefit from access to independent specialist skills, visit the Kolabtree website and post your project for free https://www.kolabtree.com/.

SourceKolabtree

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”